US Stock MarketDetailed Quotes

Vor Biopharma (VOR)

Watchlist

14.630
-0.440-2.92%

Close May 15 16:00 ET

14.410
-0.220-1.50%

Post 20:01 ET

792.74MMarket Cap-0.21P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vor Biopharma (VOR) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-23.11%-38.25M

-43.20%-142.71M

5.24%-22.8M

-130.46%-53.66M

-61.05%-35.18M

-1.97%-31.07M

0.63%-99.66M

-0.15%-24.06M

16.54%-23.29M

9.35%-21.85M

Net income from continuing operations

-575.94%-219.59M

-495.29%-695.98M

5,709.72%1.72B

-2,848.89%-812.68M

-5,552.75%-1.57B

-5.46%-32.49M

0.81%-116.91M

-16.95%-30.71M

16.97%-27.56M

7.14%-27.84M

Operating gains losses

----

18,450.00%3.3M

---2.09B

--790.46M

--1.3B

--1K

---18K

----

Depreciation and amortization

-96.61%28K

-18.17%2.89M

-97.34%23K

-99.76%2K

134.41%2.04M

-12.51%825K

1.03%3.53M

-3.03%865K

-4.70%851K

-0.11%869K

Other non cash items

14,286.95%188.47M

10,176.23%518.03M

13,688.05%334.5M

-33,846.21%-44.55M

18,026.46%226.76M

6.33%1.31M

6.64%5.04M

-50.37%2.43M

105.33%132K

6.20%1.25M

Change In working capital

-489.08%-15.54M

204,060.00%10.21M

12.22%3.16M

5,208.08%5.06M

228.76%4.63M

35.97%-2.64M

-99.23%5K

461.49%2.82M

-107.81%-99K

68.02%1.41M

-Change in prepaid assets

-2,652.81%-6.36M

301.68%1.68M

-3,737.50%-873K

55.62%-75K

14,215.00%2.86M

67.46%-231K

-125.54%-835K

-96.63%24K

-149.13%-169K

-99.09%20K

-Change in payables and accrued expense

-562.78%-9.1M

387.73%10.93M

68.32%6.21M

931.13%5M

98.91%1.1M

44.68%-1.37M

-21.37%2.24M

2,043.60%3.69M

-81.76%485K

414.95%551K

-Change in other current assets

-242.86%-20K

--0

-1,738.76%-2.11M

-72.60%151K

10.99%1.95M

300.00%14K

228.72%2.43M

117.77%129K

167.36%551K

468.13%1.76M

-Change in other current liabilities

94.18%-61K

37.18%-2.41M

94.24%-59K

97.93%-20K

-39.17%-1.28M

-13.79%-1.05M

-6.89%-3.83M

-9.28%-1.02M

-5.34%-966K

8.01%-919K

Cash from discontinued investing activities

Operating cash flow

-23.11%-38.25M

-43.20%-142.71M

5.24%-22.8M

-130.46%-53.66M

-61.05%-35.18M

-1.97%-31.07M

0.63%-99.66M

-0.15%-24.06M

16.54%-23.29M

9.35%-21.85M

Investing cash flow

Cash flow from continuing investing activities

-114,350.87%-263.24M

-150.39%-48.8M

-67,919.44%-48.97M

-617.65%-244K

-98.78%646K

-100.52%-230K

36.40%96.86M

-100.70%-72K

-100.08%-34K

288.52%52.99M

Net PPE purchase and sale

79.22%-48K

37.99%-142K

-336.11%-314K

-617.65%-244K

7,288.89%647K

-102.63%-231K

78.58%-229K

35.14%-72K

92.69%-34K

97.74%-9K

Net investment purchase and sale

-26,319,000.00%-263.19M

-150.12%-48.66M

---48.66M

--0

-100.00%-1K

-100.00%1K

34.70%97.09M

--0

277.54%53M

Cash from discontinued investing activities

Investing cash flow

-114,350.87%-263.24M

-150.39%-48.8M

-67,919.44%-48.97M

-617.65%-244K

-98.78%646K

-100.52%-230K

36.40%96.86M

-100.70%-72K

-100.08%-34K

288.52%52.99M

Financing cash flow

Cash flow from continuing financing activities

12,454.79%74.87M

843.60%503.81M

477.64%307.8M

52,458.54%21.55M

564,825.81%175.07M

-731.25%-606K

1,717.29%53.39M

213,044.00%53.29M

-76.70%41K

-114.22%-31K

Net common stock issuance

--75M

487.92%328.21M

454.58%307.95M

18,149.55%20.26M

--0

1,119.42%55.83M

370,286.67%55.53M

-71.68%111K

-115.89%-92K

Proceeds from stock option exercised by employees

96.36%-2K

163,920.37%176.93M

-122.89%-19K

2,864.29%1.94M

286,891.80%175.07M

69.78%-55K

88.30%-108K

107.50%83K

67.59%-70K

116.90%61K

Net other financing activities

76.95%-127K

43.01%-1.33M

---131K

---643K

--0

---551K

-224.27%-2.33M

----

Cash from discontinued financing activities

Financing cash flow

12,454.79%74.87M

843.60%503.81M

477.64%307.8M

52,458.54%21.55M

564,825.81%175.07M

-731.25%-606K

1,717.29%53.39M

213,044.00%53.29M

-76.70%41K

-114.22%-31K

Net cash flow

Beginning cash position

370.18%396.65M

149.79%84.36M

190.94%160.63M

145.88%192.99M

10.73%52.46M

149.79%84.36M

-43.82%33.77M

16.38%55.21M

126.68%78.49M

5.59%47.38M

Current changes in cash

-610.34%-226.61M

517.31%312.29M

709.66%236.02M

-39.00%-32.36M

351.68%140.53M

-334.50%-31.9M

292.02%50.59M

313.31%29.15M

-281.66%-23.28M

403.74%31.11M

End cash Position

224.13%170.04M

370.18%396.65M

190.94%160.63M

145.88%192.99M

10.73%52.46M

149.79%84.36M

16.38%55.21M

126.68%78.49M

Free cash flow

-22.36%-38.29M

-43.81%-143.65M

4.23%-23.12M

-131.17%-53.91M

-61.68%-35.34M

-2.35%-31.3M

1.45%-99.89M

0.01%-24.14M

17.78%-23.32M

10.79%-21.86M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-23.11%-38.25M	-43.20%-142.71M	5.24%-22.8M	-130.46%-53.66M	-61.05%-35.18M	-1.97%-31.07M	0.63%-99.66M	-0.15%-24.06M	16.54%-23.29M	9.35%-21.85M
Net income from continuing operations	-575.94%-219.59M	-495.29%-695.98M	5,709.72%1.72B	-2,848.89%-812.68M	-5,552.75%-1.57B	-5.46%-32.49M	0.81%-116.91M	-16.95%-30.71M	16.97%-27.56M	7.14%-27.84M
Operating gains losses	----	18,450.00%3.3M	---2.09B	--790.46M	--1.3B	--1K	---18K	----	----	----
Depreciation and amortization	-96.61%28K	-18.17%2.89M	-97.34%23K	-99.76%2K	134.41%2.04M	-12.51%825K	1.03%3.53M	-3.03%865K	-4.70%851K	-0.11%869K
Other non cash items	14,286.95%188.47M	10,176.23%518.03M	13,688.05%334.5M	-33,846.21%-44.55M	18,026.46%226.76M	6.33%1.31M	6.64%5.04M	-50.37%2.43M	105.33%132K	6.20%1.25M
Change In working capital	-489.08%-15.54M	204,060.00%10.21M	12.22%3.16M	5,208.08%5.06M	228.76%4.63M	35.97%-2.64M	-99.23%5K	461.49%2.82M	-107.81%-99K	68.02%1.41M
-Change in prepaid assets	-2,652.81%-6.36M	301.68%1.68M	-3,737.50%-873K	55.62%-75K	14,215.00%2.86M	67.46%-231K	-125.54%-835K	-96.63%24K	-149.13%-169K	-99.09%20K
-Change in payables and accrued expense	-562.78%-9.1M	387.73%10.93M	68.32%6.21M	931.13%5M	98.91%1.1M	44.68%-1.37M	-21.37%2.24M	2,043.60%3.69M	-81.76%485K	414.95%551K
-Change in other current assets	-242.86%-20K	--0	-1,738.76%-2.11M	-72.60%151K	10.99%1.95M	300.00%14K	228.72%2.43M	117.77%129K	167.36%551K	468.13%1.76M
-Change in other current liabilities	94.18%-61K	37.18%-2.41M	94.24%-59K	97.93%-20K	-39.17%-1.28M	-13.79%-1.05M	-6.89%-3.83M	-9.28%-1.02M	-5.34%-966K	8.01%-919K
Cash from discontinued investing activities
Operating cash flow	-23.11%-38.25M	-43.20%-142.71M	5.24%-22.8M	-130.46%-53.66M	-61.05%-35.18M	-1.97%-31.07M	0.63%-99.66M	-0.15%-24.06M	16.54%-23.29M	9.35%-21.85M
Investing cash flow
Cash flow from continuing investing activities	-114,350.87%-263.24M	-150.39%-48.8M	-67,919.44%-48.97M	-617.65%-244K	-98.78%646K	-100.52%-230K	36.40%96.86M	-100.70%-72K	-100.08%-34K	288.52%52.99M
Net PPE purchase and sale	79.22%-48K	37.99%-142K	-336.11%-314K	-617.65%-244K	7,288.89%647K	-102.63%-231K	78.58%-229K	35.14%-72K	92.69%-34K	97.74%-9K
Net investment purchase and sale	-26,319,000.00%-263.19M	-150.12%-48.66M	---48.66M	--0	-100.00%-1K	-100.00%1K	34.70%97.09M	--0	--0	277.54%53M
Cash from discontinued investing activities
Investing cash flow	-114,350.87%-263.24M	-150.39%-48.8M	-67,919.44%-48.97M	-617.65%-244K	-98.78%646K	-100.52%-230K	36.40%96.86M	-100.70%-72K	-100.08%-34K	288.52%52.99M
Financing cash flow
Cash flow from continuing financing activities	12,454.79%74.87M	843.60%503.81M	477.64%307.8M	52,458.54%21.55M	564,825.81%175.07M	-731.25%-606K	1,717.29%53.39M	213,044.00%53.29M	-76.70%41K	-114.22%-31K
Net common stock issuance	--75M	487.92%328.21M	454.58%307.95M	18,149.55%20.26M	--0	--0	1,119.42%55.83M	370,286.67%55.53M	-71.68%111K	-115.89%-92K
Proceeds from stock option exercised by employees	96.36%-2K	163,920.37%176.93M	-122.89%-19K	2,864.29%1.94M	286,891.80%175.07M	69.78%-55K	88.30%-108K	107.50%83K	67.59%-70K	116.90%61K
Net other financing activities	76.95%-127K	43.01%-1.33M	---131K	---643K	--0	---551K	-224.27%-2.33M	----	----	----
Cash from discontinued financing activities
Financing cash flow	12,454.79%74.87M	843.60%503.81M	477.64%307.8M	52,458.54%21.55M	564,825.81%175.07M	-731.25%-606K	1,717.29%53.39M	213,044.00%53.29M	-76.70%41K	-114.22%-31K
Net cash flow
Beginning cash position	370.18%396.65M	149.79%84.36M	190.94%160.63M	145.88%192.99M	10.73%52.46M	149.79%84.36M	-43.82%33.77M	16.38%55.21M	126.68%78.49M	5.59%47.38M
Current changes in cash	-610.34%-226.61M	517.31%312.29M	709.66%236.02M	-39.00%-32.36M	351.68%140.53M	-334.50%-31.9M	292.02%50.59M	313.31%29.15M	-281.66%-23.28M	403.74%31.11M
End cash Position	224.13%170.04M	370.18%396.65M	370.18%396.65M	190.94%160.63M	145.88%192.99M	10.73%52.46M	149.79%84.36M	149.79%84.36M	16.38%55.21M	126.68%78.49M
Free cash flow	-22.36%-38.29M	-43.81%-143.65M	4.23%-23.12M	-131.17%-53.91M	-61.68%-35.34M	-2.35%-31.3M	1.45%-99.89M	0.01%-24.14M	17.78%-23.32M	10.79%-21.86M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm